Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liat Vidal

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
International Journal of Antimicrobial Agents|June 26, 2012
Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patientsRon Ram, Laura Farbman, Leonard Leibovici, et al.
The Cochrane Database of Systematic Reviews|January 20, 2012
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapyAnat Gafter-Gvili, Abigail Fraser, Mical Paul, et al.
Journal of the National Cancer Institute|October 25, 2011
Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trialsLiat Vidal, Anat Gafter-Gvili, Gilles Salles, et al.
Haematologica|August 10, 2012
Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysisRonit Gurion, Anat Gafter-Gvili, Liat Vidal, et al.
Leukemia Research|July 16, 2013
The role of ¹⁸F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropeniaAnat Gafter-Gvili, Mical Paul, Hanna Bernstine, et al.
American Journal of Hematology|July 16, 2011
High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients--systematic review and meta-analysisAnat Gafter-Gvili, Avi Leader, Ronit Gurion, et al.
Leukemia & Lymphoma|May 7, 2015
Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center studyAnat Gafter-Gvili, Elena Ribakovsky, Nadav Mizrahi, et al.
Leukemia & Lymphoma|May 20, 2021
Eltrombopag for enhancement of platelet engraftment in patients undergoing allogeneic cord blood transplantationOren Pasvolsky, Liat Shargian, Uri Rozovski, et al.
American Journal of Hematology|November 2, 2013
Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trialMical Paul, Ron Ram, Eitan Kugler, et al.
American Journal of Public Health|November 15, 2008
Cancer screening in US workersLiat Vidal, William G LeBlanc, Kathryn E McCollister, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
International Journal of Antimicrobial Agents|June 26, 2012
Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patientsRon Ram, Laura Farbman, Leonard Leibovici, et al.
The Cochrane Database of Systematic Reviews|January 20, 2012
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapyAnat Gafter-Gvili, Abigail Fraser, Mical Paul, et al.
Journal of the National Cancer Institute|October 25, 2011
Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trialsLiat Vidal, Anat Gafter-Gvili, Gilles Salles, et al.
Haematologica|August 10, 2012
Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysisRonit Gurion, Anat Gafter-Gvili, Liat Vidal, et al.
Leukemia Research|July 16, 2013
The role of ¹⁸F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropeniaAnat Gafter-Gvili, Mical Paul, Hanna Bernstine, et al.
American Journal of Hematology|July 16, 2011
High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients--systematic review and meta-analysisAnat Gafter-Gvili, Avi Leader, Ronit Gurion, et al.
Leukemia & Lymphoma|May 7, 2015
Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center studyAnat Gafter-Gvili, Elena Ribakovsky, Nadav Mizrahi, et al.
Leukemia & Lymphoma|May 20, 2021
Eltrombopag for enhancement of platelet engraftment in patients undergoing allogeneic cord blood transplantationOren Pasvolsky, Liat Shargian, Uri Rozovski, et al.
American Journal of Hematology|November 2, 2013
Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trialMical Paul, Ron Ram, Eitan Kugler, et al.
American Journal of Public Health|November 15, 2008
Cancer screening in US workersLiat Vidal, William G LeBlanc, Kathryn E McCollister, et al.
Pageof 7